Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death

INTRODUCTION: Estrogen deprivation using aromatase inhibitors (AIs) is currently the standard of care for postmenopausal women with hormone receptor-positive breast cancer. Unfortunately, the majority of patients treated with AIs eventually develop resistance, inevitably resulting in patient relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hye Joung, Lui, Asona, Ogony, Joshua, Jan, Rifat, Sims, Peter J, Lewis-Wambi, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336497/
https://www.ncbi.nlm.nih.gov/pubmed/25588716
http://dx.doi.org/10.1186/s13058-014-0506-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336497/
https://www.ncbi.nlm.nih.gov/pubmed/25588716
http://dx.doi.org/10.1186/s13058-014-0506-7

Ejemplares similares